Efonidipine
From Infogalactic: the planetary knowledge core
Systematic (IUPAC) name | |
---|---|
2-(phenyl-(phenylmethyl)amino)ethyl 5-(5,5-dimethyl-2-oxo-1,3-dioxa-2λ5-phosphacyclohex-2-yl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylate
|
|
Clinical data | |
Trade names | Landel (ランデル) |
AHFS/Drugs.com | International Drug Names |
Legal status |
|
Routes of administration |
Oral |
Identifiers | |
CAS Number | 111011-63-3 |
ATC code | none |
PubChem | CID: 119171 |
ChemSpider | 106463 |
UNII | 40ZTP2T37Q |
ChEMBL | CHEMBL2074922 |
Chemical data | |
Formula | C34H38N3O7P |
Molecular mass | 631.65 g/mol |
|
|
|
|
(what is this?) (verify) |
Efonidipine (INN) is a dihydropyridine calcium channel blocker marketed by Shionogi & Co. of Japan. It was launched in 1995, under the brand name Landel (ランデル). The drug blocks both T-type and L-type calcium channels.[1]
It has also been studied in atherosclerosis[2] and acute renal failure.[3]
References
- (Japanese) Landel ランデル (PDF) Shionogi & Co. April 2005.
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Drugs with non-standard legal status
- Chemical articles having calculated molecular weight overwritten
- Articles with changed InChI identifier
- Infobox drug articles without a structure image
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs not assigned an ATC code
- Articles with Japanese-language external links
- Calcium channel blockers
- Dihydropyridines
- Nitrobenzenes
- Carboxylate esters
- Phosphonate esters
- Anilines
- Cardiovascular system drug stubs